What are the recommended dosing and infusion parameters for remifentanil (including loading dose, continuous infusion rates, concentrations, and monitoring) in adult and pediatric patients?

Remifentanil Dosing and Infusion Parameters

For pediatric patients undergoing intraoperative analgesia, use remifentanil at a continuous infusion rate of 0.05 to 0.3 mcg/kg/min, and for adults undergoing general anesthesia, initiate at 0.5-1 mcg/kg/min for induction followed by 0.25-0.4 mcg/kg/min for maintenance depending on the concurrent anesthetic agent. 1, 2

Adult Dosing

Induction of Anesthesia

• Infusion rate: 0.5-1 mcg/kg/min with a hypnotic or volatile agent 2
• Alternative bolus: If intubation occurs within 8 minutes, administer 1 mcg/kg over 30-60 seconds 2
• Critical caveat: Never use remifentanil as sole induction agent—loss of consciousness cannot be assured, and high incidence of apnea, muscle rigidity, and tachycardia occurs 2

Maintenance of Anesthesia

The maintenance dose varies significantly based on concurrent anesthetic:

• With nitrous oxide (66%): 0.4 mcg/kg/min (range: 0.1-2 mcg/kg/min) 2
• With isoflurane (0.4-1.5 MAC): 0.25 mcg/kg/min (range: 0.05-2 mcg/kg/min) 2
• With propofol (100-200 mcg/kg/min): 0.25 mcg/kg/min (range: 0.05-2 mcg/kg/min) 2

Titration Strategy

• Upward adjustments: Increase by 25-100% increments every 2-5 minutes 2
• Downward adjustments: Decrease by 25-50% decrements every 2-5 minutes 2
• Supplemental boluses: 1 mcg/kg every 2-5 minutes for light anesthesia or intense surgical stress 2
• Upper limit consideration: At infusion rates >1 mcg/kg/min, increase concurrent anesthetic agents rather than further escalating remifentanil 2

Postoperative Analgesia (Adults Only)

• Initial rate: 0.1 mcg/kg/min 2
• Titration: Adjust by 0.025 mcg/kg/min increments every 5 minutes 2
• Maximum safe rate: 0.2 mcg/kg/min (higher rates associated with respiratory depression) 2
• Critical timing: No residual analgesia within 5-10 minutes after discontinuation—alternative analgesics must be administered before stopping remifentanil 2

Pediatric Dosing

Children 1-12 Years

• Maintenance infusion: 0.25 mcg/kg/min (range: 0.05-1.3 mcg/kg/min) 1, 2
• Supplemental bolus: 1 mcg/kg over 30-60 seconds 2
• Titration: Increase up to 50% increments (more conservative than adults) 2
• Compatible with: Halothane (0.3-1.5 MAC), sevoflurane (0.3-1.5 MAC), or isoflurane (0.4-1.5 MAC) 2

Neonates (Birth to 2 Months)

• Maintenance infusion: 0.4 mcg/kg/min (range: 0.4-1.0 mcg/kg/min) with nitrous oxide 70% 2
• Supplemental bolus: 1 mcg/kg (studied in ASA 1-2, full-term patients ≥2500 gm with atropine pretreatment) 2
• Critical consideration: Clearance is highly variable and on average 2× higher than young adults—may require increased infusion rates 2
• Atropine pretreatment: Essential to blunt bradycardia 2
• High-risk situations: Neonates with significant comorbidities, undergoing fluid shifts, or without atropine pretreatment require smaller bolus doses to avoid hypotension/bradycardia 2

Pediatric Postoperative Use

Not recommended—remifentanil has not been studied in pediatric patients for immediate postoperative period use 2

Preparation and Concentrations

The FDA label does not specify exact concentrations, but the drug must be reconstituted and diluted appropriately for continuous infusion. Standard practice involves preparing concentrations that allow precise weight-based dosing through infusion pumps.

Monitoring Requirements

Essential Monitoring

• Continuous respiratory monitoring: High risk of apnea and respiratory depression 2
• Hemodynamic monitoring: Blood pressure and heart rate (risk of hypotension and bradycardia) 3, 2
• Oxygen saturation: Continuous pulse oximetry 2
• Preparedness for intervention: Immediate availability of airway management equipment and reversal agents 2

Specific Adverse Effects to Monitor

• Chest wall rigidity: Common side effect, particularly with rapid administration—manage with slow continuous infusion and minimum effective doses 4
• Hypotension: Occurs in approximately 17% of pediatric patients receiving 5 mcg/kg bolus 5
• Bradycardia: Especially in pediatric patients—atropine may be needed 2

Critical Clinical Pearls

Synergistic Effects

Remifentanil is highly synergistic with other anesthetics—reduce doses of thiopental, propofol, isoflurane, and midazolam by up to 75% when coadministering remifentanil 2

Context-Specific Dosing

The optimal dose varies by clinical context. For example, the ED80 for achieving 30-second apnea during cardiac MRI in children is 0.184 mcg/kg/min 6, while the ED90 for outpatient hysteroscopy with propofol is 2.75 ng/mL effect-site concentration 7.

Hyperalgesia Risk

Infusion doses >0.2 mcg/kg/min are associated with chronic postsurgical pain development after video-assisted thoracic surgery 8. This represents a critical threshold for balancing analgesia against long-term harm.

Pharmacokinetic Considerations

• Neonates and young infants: Faster clearance (90-92 mL/kg/min) compared to older children (46-76 mL/kg/min) 5
• Half-life: Remarkably consistent across all ages (3.4-5.7 minutes) 5
• Volume of distribution: Largest in infants <2 months (452 mL/kg), decreasing to 223-308 mL/kg in older patients 5

Cardiopulmonary Bypass Adjustments

During CPB, volume of distribution increases to 2.41 times pre-CPB values—dosage adjustments required during and after CPB 9